Clinical Trials on Pheochromocytoma in Canada
Total 7 results
-
University Health Network, TorontoPfizerCompletedPheochromocytoma | ParagangliomaCanada, Netherlands
-
Vancouver Coastal HealthUnknownNeuroblastoma | Pheochromocytoma | Paraganglioma | Medullary Thyroid Carcinoma | Carcinoid TumorsCanada
-
British Columbia Cancer AgencyNo longer availableThyroid Cancer, Medullary | Neuroblastoma | Pheochromocytoma | Carcinoid Tumor | Paraganglioma | InsulinomaCanada
-
Ottawa Regional Cancer CentreCompletedSarcoma | Head and Neck Cancer | Brain and Central Nervous System Tumors | Malignant Mesothelioma | Liver Cancer | Pheochromocytoma | Adrenocortical CarcinomaCanada
-
British Columbia Cancer AgencyRecruitingPituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary CarcinomaCanada
-
Merck Sharp & Dohme LLCRecruitingVon Hippel-Lindau Disease | Pancreatic Neuroendocrine Tumor | Pheochromocytoma/Paraganglioma | Advanced Gastrointestinal Stromal Tumor | HIF-2α Mutated CancersCanada, United States, Denmark, France, Germany, Hungary, Italy, Russian Federation, Spain, Sweden, Turkey, Israel, United Kingdom, Netherlands, Australia, China, Singapore, Japan
-
European Organisation for Research and Treatment...NCIC Clinical Trials GroupCompletedSarcoma | Kidney Cancer | Ovarian Cancer | Endometrial Cancer | PheochromocytomaFrance, Canada, Switzerland, Denmark, Belgium, Netherlands, United Kingdom, Germany, Italy, Slovakia, Spain, Portugal, Austria